Gritstone bio Equity 2024

Gritstone bio Aktienanalyse

What does Gritstone bio do?

Gritstone Oncology Inc. is a biotechnology company based in California, USA, that develops innovative cancer immunotherapies. It was founded in 2015 by Dr. Andrew Allen and Dr. Alex Chaudhuri, and has been listed on the Nasdaq stock exchange with the ticker "GRTS" since 2018. The founders previously worked in the field of immunotherapy at Roche and Takeda and recognized the potential of personalized cancer therapies using immunology and cancer genomics technologies. With funding of over $220 million from investors such as Versant Ventures, The Column Group, and Frazier Healthcare Partners, the company has experienced strong growth in recent years. Gritstone Oncology follows an integrated business model that includes innovative platform technologies for identifying tumor antigens and developing personalized immunotherapies. The company uses advanced sequencing technologies and data analysis methods to detect individual cancer mutations and develop tailored therapies. Gritstone Oncology has two main product categories: cancer immunotherapies and cancer diagnostics. The company is developing various immunotherapies for the treatment of cancer, including a novel SARS-CoV-2/COVID-19 vaccine based on the same platform as their cancer immunotherapies. Additionally, Gritstone Oncology has developed a proprietary platform for the development of bispecific antibodies, which can simultaneously target two different objectives. They are also developing personalized immunotherapies that specifically target an individual patient's cancer mutations. The company also offers diagnostic tests to identify cancer mutations and determine therapeutic options. These include GPS Cancer, a genomic test that enables personalized cancer diagnosis and therapy, and SLATE, a diagnostic test that analyzes the immune status of tumor cells and surrounding tissues to develop personalized immunotherapy. In conclusion, Gritstone Oncology has become a leading company in the field of personalized cancer immunotherapy. It has strong growth potential due to its innovative technologies and research, as well as its highly experienced leadership and employees. The company will continue to play a critical role in cancer research and therapy and has the potential to improve the lives of millions of people worldwide. Gritstone bio ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Gritstone bio's Equity

Gritstone bio's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Gritstone bio's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Gritstone bio's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Gritstone bio's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Gritstone bio’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Gritstone bio stock

What is the equity of Gritstone bio this year?

Gritstone bio has equity of 51.85 M USD this year.

What was the equity of Gritstone bio compared to the previous year?

The equity of Gritstone bio has increased/decreased by -69.64% decreased compared to the previous year.

What impact does a high equity have on investors of Gritstone bio?

A high equity is advantageous for investors of Gritstone bio as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Gritstone bio?

A low equity can be a risk for investors of Gritstone bio, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Gritstone bio affect the company?

An increase in equity of Gritstone bio can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Gritstone bio affect the company?

A reduction in equity of Gritstone bio can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Gritstone bio?

Some factors that can affect the equity of Gritstone bio include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Gritstone bio so important for investors?

The equity of Gritstone bio is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Gritstone bio take to change the equity?

To change equity, Gritstone bio can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Gritstone bio pay?

Over the past 12 months, Gritstone bio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Gritstone bio is expected to pay a dividend of 0 USD.

What is the dividend yield of Gritstone bio?

The current dividend yield of Gritstone bio is .

When does Gritstone bio pay dividends?

Gritstone bio pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Gritstone bio?

Gritstone bio paid dividends every year for the past 0 years.

What is the dividend of Gritstone bio?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Gritstone bio located?

Gritstone bio is assigned to the 'Health' sector.

Wann musste ich die Aktien von Gritstone bio kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Gritstone bio from 9/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.

When did Gritstone bio pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of Gritstone bio in the year 2023?

In the year 2023, Gritstone bio distributed 0 USD as dividends.

In which currency does Gritstone bio pay out the dividend?

The dividends of Gritstone bio are distributed in USD.